Completed
Phase 3
Age: 18Years - 80Years
All Genders
ID00000540
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-11-07
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To test the hypothesis that implantable cardioverter defibrillator (ICD) therapy will improve survival in coronary heart disease patients at high risk of death, especially arrhythmic death.
CONDITIONS
Official Title
Coronary Artery Bypass Graft (CABG) Patch Trial
Who Can Participate
Age: 18Years - 80Years
All Genders
Eligibility Criteria
You may qualify if you...
Men and women, up to age 80, with a left ventricular ejection fraction less than .36 and an abnormal signal averaged electrocardiogram.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Surgical aspects of a randomized trial of defibrillator implantation during coronary artery bypass surgery. The CABG Patch Trial.
H M Spotnitz, J M Herre, L D Baker...
https://pubmed.ncbi.nlm.nih.gov/8901755The risks of reoperative coronary artery bypass in chronic ischemic cardiomyopathy: results of the CABG Patch Trial.
I L Kron, J T Cope, L D Baker...
https://pubmed.ncbi.nlm.nih.gov/9386070Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.
J T Bigger
https://pubmed.ncbi.nlm.nih.gov/9371853Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.
A B Curtis, D S Cannom, J T Bigger...
https://pubmed.ncbi.nlm.nih.gov/9398090Changes in sample size and length of follow-up to maintain power in the coronary artery bypass graft (CABG) patch trial.
J T Bigger, M K Parides, L M Rolnitzky...
https://pubmed.ncbi.nlm.nih.gov/9492965Influence of the preoperative signal-averaged electrocardiogram on left ventricular function after coronary artery bypass graft surgery in patients with left ventricular dysfunction. The CABG Patch Trial.
J R Cook, J E Flack, C A Gregory...
https://pubmed.ncbi.nlm.nih.gov/9708654Effect of implantable cardioverter-defibrillator implantation on surgical morbidity in the CABG Patch Trial. Surgical Investigators of the Coronary Artery Bypass Graft Patch Trial.
H M Spotnitz, J M Herre, S T Raza...
https://pubmed.ncbi.nlm.nih.gov/9852885Epicardial cardioverter-defibrillators do not cause postoperative arrhythmias. The CABG Patch Trial Investigators. Coronary Artery Bypass Graft.
A B Curtis, J T Bigger, J P DiMarco...
https://pubmed.ncbi.nlm.nih.gov/9817491Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial.
P B Namerow, B R Firth, G M Heywood...
https://pubmed.ncbi.nlm.nih.gov/10527011